Literature DB >> 1667935

Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules.

C C Dykstra1, R R Tidwell.   

Abstract

Pentamidine and related derivatives inhibit an ATP-dependent topoisomerase activity from Pneumocystis carinii extracts. Since it would be extremely difficult to purify ample quantities of the organisms to allow characterization of the enzyme and carry out drug binding experiments, we have begun the cloning of the topoisomerase genes with a goal towards expression of each gene in a heterologous system. Following construction of genomic libraries in the vectors lambda DASH and lambda ZAP, oligonucleotides corresponding to conserved regions of both topoisomerases I and II were used in the polymerase chain reaction (PCR) of P. carinii DNA to generate probes. Candidate clones for both genes have been identified. Partial DNA sequence of the topoisomerase II gene has been determined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667935

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  22 in total

1.  Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.

Authors:  M Del Poeta; D L Toffaletti; T H Rude; C C Dykstra; J Heitman; J R Perfect
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

2.  Synthesis of dicationic diarylpyridines as nucleic-acid binding agents.

Authors:  A Kumar; Ra Rhodes; J Spychala; Wd Wilson; Dw Boykin; Rr Tidwell; Cc Dykstra; Je Hall; Sk Jones; Rf Schinazi
Journal:  Eur J Med Chem       Date:  1995       Impact factor: 6.514

3.  Pentamidine reduces hERG expression to prolong the QT interval.

Authors:  Jason S Cordes; Zhuoqian Sun; David B Lloyd; Jenifer A Bradley; Alan C Opsahl; Mark W Tengowski; Xian Chen; Jun Zhou
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

4.  In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.

Authors:  Melanie T Cushion; Peter D Walzer; Alan Ashbaugh; Sandra Rebholz; Ronald Brubaker; Jean Jacques Vanden Eynde; Annie Mayence; Tien L Huang
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.

Authors:  M T Cushion; M Collins; B Hazra; E S Kaneshiro
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia.

Authors:  R R Tidwell; S K Jones; N A Naiman; L C Berger; W B Brake; C C Dykstra; J E Hall
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

7.  Synthesis of dicationic diaryltriazines nucleic acid binding agents.

Authors:  J Spychala; Dw Boykin; Wd Wilson; M Zhao; Rr Tidwell; Cc Dykstra; Je Hall; Sk Jones; Rf Schinazi
Journal:  Eur J Med Chem       Date:  1994       Impact factor: 6.514

8.  Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

Authors:  P D Walzer; J Foy; J Runck; P Steele; M White; R S Klein; B A Otter; R J Sundberg
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  Characterization of the PNT1 pentamidine resistance gene of Saccharomyces cerevisiae.

Authors:  G Ludewig; C Staben
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model.

Authors:  J A Fishman; S F Queener; R S Roth; M S Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.